- Report
- November 2022
- 253 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- September 2022
- 231 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- July 2022
- 231 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- May 2022
- 244 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- May 2022
- 156 Pages
Middle East
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- March 2022
- 273 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- February 2022
- 230 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- January 2022
- 294 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- December 2021
- 226 Pages
Global
From €2496EUR$2,625USD£2,100GBP
€4992EUR$5,250USD£4,200GBP
- Report
- November 2021
- 138 Pages
Global
From €1248EUR$1,313USD£1,050GBP
€2496EUR$2,625USD£2,100GBP
- Report
- January 2024
- 492 Pages
Global
From €4422EUR$4,650USD£3,720GBP
- Report
- February 2022
- 312 Pages
Global
From €2853EUR$3,000USD£2,400GBP
- Report
- February 2024
- 442 Pages
Global
From €4422EUR$4,650USD£3,720GBP
- Report
- December 2023
- 192 Pages
Global
From €4422EUR$4,650USD£3,720GBP
- Report
- October 2023
- 154 Pages
Global
From €4422EUR$4,650USD£3,720GBP
- Report
- July 2023
- 200 Pages
Global
From €4422EUR$4,650USD£3,720GBP
- Report
- March 2023
- 164 Pages
Global
From €2377EUR$2,500USD£2,000GBP
- Report
- October 2022
- 147 Pages
Global
From €5230EUR$5,500USD£4,400GBP
- Report
- December 2018
- 235 Pages
Global
From €1307EUR$1,375USD£1,100GBP
€2615EUR$2,750USD£2,200GBP
- Report
- May 2018
- 171 Pages
China
From €1307EUR$1,375USD£1,100GBP
€2615EUR$2,750USD£2,200GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more